Tag: Atrial Fibrillation
DAPT Use Variable in Patients With A-Fib at Risk of Stroke
Dual antiplatelet therapy used in variable manner; most patients remain on study drug after PCI
Usual Apixaban Dosing OK With One Dose-Reduction Criterion
5 mg apixaban twice daily deemed safe, appropriate for those with one criterion in ARISTOTLE trial